Cargando…

Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.

Detalles Bibliográficos
Autores principales:	Shelley, M. D., Fish, R. G., Adams, M., Kerby, I.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977101/ https://www.ncbi.nlm.nih.gov/pubmed/4040769

Ejemplares similares

Proliferative defects in renal and intestinal epithelium after cis-dichlorodiammine platinum (II).
por: Kovacs, C. J., et al.
Publicado: (1982)

Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancer.
por: Balconi, G., et al.
Publicado: (1991)

cis-Dichloridobis(triisopropoxyphosphine)platinum(II)
por: Slawin, Alexandra M. Z., et al.
Publicado: (2009)

cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.
por: Wilson, A. P., et al.
Publicado: (1987)

cis-Dimethylbis(triphenylarsine)platinum(II)
por: Abo-Amer, Anwar
Publicado: (2010)

Small intestinal mucosal toxicity of cis-platinum--comparison of toxicity with platinum analogues and dexamethasone.
por: Allan, S. G., et al.
Publicado: (1986)

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
por: Cantón-Romero, Juan Carlos, et al.
Publicado: (2017)

UVA-Photosensitivity of cis-Diamminedichloro-Platinum(II)-Modified DNA
por: Payet, Dominique, et al.
Publicado: (1995)

cis-Bis(2-sulfidopyridine N-oxide)platinum(II)
por: Ravindran Durai Nayagam, B., et al.
Publicado: (2008)

A highly constrained cis-dihydride platinum complex trapped by cooperative gold/platinum dihydrogen activation
por: Hidalgo, Nereida, et al.
Publicado: (2022)

Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity
por: Möltgen, Sophie, et al.
Publicado: (2020)

cis-Dichloridobis(2-phenylpyridine-κN)platinum(II)
por: Yoshinari, Nobuto, et al.
Publicado: (2010)

cis-Dibromidobis(2-phenylpyridine-κN)platinum(II)
por: Ha, Kwang
Publicado: (2012)

Crystal structure of cis-diamminebis(nitrito-κN)platinum(II)
por: Kahlenberg, Volker, et al.
Publicado: (2015)

Crystal and molecular structure of cis-Dichlorobis(triphenyl-phosphite) Platinum(II)
por: Sabounchei, Seyyed Javad, et al.
Publicado: (2001)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
por: Stratford, I. J., et al.
Publicado: (1980)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Sister chromatid exchanges induced by two radiosensitizing platinum compounds (cis-dichloro-bis isopropylamine trans dihydroxy platinum IV (CHIP) and cis platinum metronidazole2Cl2(FLAP] in CHO cells in vitro.
por: Bocian, E., et al.
Publicado: (1983)

cis-Dichloridobis(quinoline-κN)platinum(II) nitromethane monosolvate
por: Ha, Kwang
Publicado: (2012)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
Publicado: (2014)

Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
por: Yew, Kok-Hooi, et al.
Publicado: (2013)

Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
por: Chien, Jeremy, et al.
Publicado: (2013)

Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
por: Guerra Alía, Eva María, et al.
Publicado: (2019)

Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2020)

Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study
por: Kunos, Charles, et al.
Publicado: (2012)

Studies with cis-diamminedichloro-platinum II and exogenous polyamines using mammalian cells in culture.
por: Roizin-Towle, L.
Publicado: (1981)

cis-Diammine(glycolato-κ(2) O (1),O (2))platinum(II)
por: Wang, Qing-Kun, et al.
Publicado: (2009)

cis-Dichloridobis(triphenylphosphine-κP)platinum(II) chloroform solvate
por: Miao, Jinling, et al.
Publicado: (2009)

Correction: Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
por: Yew, Kok-Hooi, et al.
Publicado: (2013)

Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient
por: Colombo, Nicoletta
Publicado: (2014)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis
por: da Costa, Alexandre André Balieiro Anastácio, et al.
Publicado: (2019)

Systematic Review of Olaparib in the Treatment of Recurrent Platinum Sensitive Ovarian Cancer
por: Chen, Qian, et al.
Publicado: (2022)

Combined Cis-platinum and Alpha Interferon Therapy of Advanced Hepatocellular Carcinoma
por: Ji, Sang Keun, et al.
Publicado: (1996)

Palladium and Platinum 2,4-cis-amino Azetidine and Related Complexes
por: Yoshizawa, Akina, et al.
Publicado: (2018)

Real-time assessment of platinum sensitivity of primary culture from a patient with ovarian cancer with extensive metastasis and the platinum sensitivity enhancing effect by metformin
por: Liu, Yingzhao, et al.
Publicado: (2018)

Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours.
por: Sargent, J. M., et al.
Publicado: (1996)

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
por: Gonzalez-Ochoa, Eduardo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_56c2ds4pn7a21cbreuancgtkb0